PL416041A1 - Application of naringenin and naringenin-containing preparation, and method for slowing down, counteracting and preventing the process of formation of albinotic spots on skin - Google Patents

Application of naringenin and naringenin-containing preparation, and method for slowing down, counteracting and preventing the process of formation of albinotic spots on skin

Info

Publication number
PL416041A1
PL416041A1 PL416041A PL41604116A PL416041A1 PL 416041 A1 PL416041 A1 PL 416041A1 PL 416041 A PL416041 A PL 416041A PL 41604116 A PL41604116 A PL 41604116A PL 416041 A1 PL416041 A1 PL 416041A1
Authority
PL
Poland
Prior art keywords
naringenin
preventing
formation
application
skin
Prior art date
Application number
PL416041A
Other languages
Polish (pl)
Other versions
PL229597B1 (en
Inventor
Irena Szołomicka-Orfinger
Katarzyna Rogiewicz
Renata Dębowska
Elżbieta Jakimiuk
Małgorzata Szubert
Karolina Bazela
Monika Pasikowska
Piotr Bednarczyk
Jerzy Duszyński
Joanna Szczepanowska
Adam Szewczyk
Mariusz Więckowski
Original Assignee
Laboratorium Kosmetyczne Dr Irena Eris Spółka Z Ograniczoną Odpowiedzialnością
Instytut Biologii Doświadczalnej Pan Im. M. Nenckiego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorium Kosmetyczne Dr Irena Eris Spółka Z Ograniczoną Odpowiedzialnością, Instytut Biologii Doświadczalnej Pan Im. M. Nenckiego filed Critical Laboratorium Kosmetyczne Dr Irena Eris Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL416041A priority Critical patent/PL229597B1/en
Publication of PL416041A1 publication Critical patent/PL416041A1/en
Publication of PL229597B1 publication Critical patent/PL229597B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Zgłoszenie dotyczy zastosowania naryngeniny w skutecznej ilości do spowalniania, przeciwdziałania i zapobiegania procesowi powstawania plam bielaczych skóry. Zgłoszenie dotyczy także preparatu zawierającego jako substancję czynną naryngeninę w skutecznej ilości oraz kosmetycznie dopuszczalne zaróbki, nośniki i substancje dodatkowe, do stosowania do spowalniania, przeciwdziałania i zapobiegania procesowi powstawania plam bielaczych skóry a także dotyczy sposobu spowalniania, przeciwdziałania i zapobiegania procesowi powstawania plam bielaczych skóry.The application relates to the use of narngenine in an effective amount to slow down, prevent and prevent the formation of vitiligo skin patches. The application also concerns a preparation containing as an active substance narngenine in an effective amount and cosmetically acceptable excipients, carriers and additional substances, to be used to slow down, counteract and prevent the formation of vitiligo patches as well as the method of slowing, preventing and preventing the process of vitiligo patches.

PL416041A 2016-02-04 2016-02-04 Application of naringenin and naringenin-containing preparation, and method for slowing down, counteracting and preventing the process of formation of albinotic spots on skin PL229597B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL416041A PL229597B1 (en) 2016-02-04 2016-02-04 Application of naringenin and naringenin-containing preparation, and method for slowing down, counteracting and preventing the process of formation of albinotic spots on skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL416041A PL229597B1 (en) 2016-02-04 2016-02-04 Application of naringenin and naringenin-containing preparation, and method for slowing down, counteracting and preventing the process of formation of albinotic spots on skin

Publications (2)

Publication Number Publication Date
PL416041A1 true PL416041A1 (en) 2017-08-16
PL229597B1 PL229597B1 (en) 2018-08-31

Family

ID=59579251

Family Applications (1)

Application Number Title Priority Date Filing Date
PL416041A PL229597B1 (en) 2016-02-04 2016-02-04 Application of naringenin and naringenin-containing preparation, and method for slowing down, counteracting and preventing the process of formation of albinotic spots on skin

Country Status (1)

Country Link
PL (1) PL229597B1 (en)

Also Published As

Publication number Publication date
PL229597B1 (en) 2018-08-31

Similar Documents

Publication Publication Date Title
MX2019002750A (en) Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer.
BR112019018093A2 (en) COMPOUNDS, COMPOSITION, HPK1 INHIBITION METHOD, METHODS TO IMPROVE AN IMMUNE RESPONSE AND TO TREAT A DISORDER AND COMPOUND USES
MX2019011530A (en) 11,13-modified saxitoxins for the treatment of pain.
EA201892680A1 (en) COMPOSITION FOR HAIR STRENGTHENING AND METHOD OF HAIR STRENGTHENING
SG10201811841UA (en) Methods of treating cancer using tigit inhibitors and anti-cancer agents
MX370664B (en) SELECTIVE GLUCOSE-REGULATED PROTEIN 94 (GPR94) INHIBITORS AND USES OF THEM.
SG10201909199PA (en) Method for treating cancer
BR112017005598A2 (en) peptidomimetic macrocycles and their uses
MX361100B (en) Shaping keratin fibres using a sugar.
CL2018000963A1 (en) Cosmetic that has probiotic bacteria
IN2015DN02938A (en)
EA201492040A1 (en) BICYCLICALLY SUBSTITUTED URACILES AND THEIR APPLICATION
MX2021008305A (en) Anti-cd40 antibodies for use in treatment of hidradenitis suppurativa.
MX2019004314A (en) Topical dressing composition for the treatment of damaged skin tissue.
BR112016009178A8 (en) method of preparing a tissue product, and, using a tissue product
BR112016016870A8 (en) icariin derivatives, their uses, and pharmaceutical composition
BR112016025333A2 (en) agent, product and use
MX2018000274A (en) Ammonia oxidizing bacteria for treatment of acne.
MX367321B (en) Skin care composition and method thereof.
WO2013060707A3 (en) Cosmetic agents containing oxytocin and aromatic substances
MX388461B (en) ACETYL-LEUCINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TO IMPROVE MOBILITY AND COGNITIVE FUNCTION.
SG11201901617PA (en) Azole compound ophthalmic preparation
MX394047B (en) A COMPOSITION COMPRISING A COMBINATION OF SCHINUS TEREBINTHIFOLIUS EXTRACT AND CAFFEINE.
SG11201804615SA (en) Hair cosmetic
BR112017023316A2 (en) cosmetic method and therapeutic use for fat reduction